Akira Mogami

Amiselimod, a novel sphingosine 1‐phosphate receptor‐1 modulator, has potent therapeutic efficacy for autoimmune diseases, with low bradycardia risk

Kunio Sugahara, Yasuhiro Maeda, Kyoko Shimano et al. · British Journal of Pharmacology · 2016 · 83 citations · Full text

Cytotoxic Necrotizing Factor Type 2 Produced by Pathogenic <i>Escherichia coli</i> Deamidates a Gln Residue in the Conserved G-3 Domain of the Rho Family and Preferentially Inhibits the GTPase Activity of RhoA and Rac1

Motoyuki Sugai, Kiyotaka Hatazaki, Akira Mogami et al. · Infection and Immunity · 1999 · 33 citations · Full text

Y-40138, a multiple cytokine production modulator, protects against d-galactosamine and lipopolysaccharide-induced hepatitis

Tetsuko Fukuda, Akira Mogami, Hideki Tanaka et al. · Life Sciences · 2006 · 32 citations

Inflammation, Autoimmune Disease, Viral Hepatitis +10

Genetic characteristics and antibiotic resistance of Haemophilus influenzae isolates from pediatric patients with acute otitis media after introduction of 13-valent pneumococcal conjugate vaccine in Japan

Kimiko Ubukata, Miyuki Morozumi, Megumi Sakuma et al. · Journal of Infection and Chemotherapy · 2019 · 21 citations

Antibiotics, Healthcare-associated Infection, Pediatric Patients +9

Small GTP-binding protein Rho-mediated signaling promotes proliferation of rheumatoid synovial fibroblasts

Shingo Nakayamada, Hitoshi Kurose, Kazuyoshi Saito et al. · Arthritis Research & Therapy · 2005 · 20 citations · Full text